The Fondation Maladies Rares, in partnership with Novo Nordisk, is proud to announce the winner of the "Improving quality of life for sickle cell disease patients" research grant for 2023.
The recipient of this award is Dr Damien Oudin Doglioni from the LIP/PC2S Laboratory at Grenoble Alpes University. His project, entitled "Adaptation and evaluation of the feasibility of the FACETS fatigue management program in adult patients with sickle cell disease", was selected for its potential to bring significant advances in the field.
This promising research, focused on improving the quality of life of people with sickle cell disease, is in line with the commitments of the Fondation Maladies Rares and Novo Nordisk to medical progress.
Dr Damien Oudin Doglioni and his team are warmly congratulated for their outstanding dedication to rare disease research. This recognition underlines the crucial importance of their work in the healthcare field, and raises hopes for future medical advances.
Find out more about the project here